Literature DB >> 26398078

Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction.

Marc P Bonaca, Eugene Braunwald, Marc S Sabatine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26398078     DOI： 10.1056/NEJMc1508692

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

Review 1.  Long-Term Use of Ticagrelor in Patients with Coronary Artery Disease.

Authors:  Sara Ariotti; Giuseppe Gargiulo; Marco Valgimigli
Journal:  Curr Cardiol Rep       Date:  2017-01       Impact factor: 2.931

Review 2.  Dual antiplatelet therapy after percutaneous coronary intervention for stable CAD or ACS : Redefining the optimal duration of treatment.

Authors:  B E Stähli; U Landmesser
Journal:  Herz       Date:  2018-02       Impact factor: 1.443

Review 3.  A Comprehensive Review of the Pleiotropic Effects of Ticagrelor.

Authors:  Jeffrey Triska; Neil Maitra; Matthew R Deshotels; Faris Haddadin; Dominick J Angiolillo; Gemma Vilahur; Hani Jneid; Dan Atar; Yochai Birnbaum
Journal:  Cardiovasc Drugs Ther       Date:  2022-08-24       Impact factor: 3.947

4.  [Management of acute coronary syndrome without ST-segment elevation].

Authors:  Maria Rubini Gimenez; Holger Thiele; Janine Pöss
Journal:  Herz       Date:  2022-06-14       Impact factor: 1.740

Review 5.  Dual Antiplatelet Therapy Duration: Reconciling the Inconsistencies.

Authors:  Francesco Costa; Stephan Windecker; Marco Valgimigli
Journal:  Drugs       Date:  2017-10       Impact factor: 9.546

6.  Rationale and design of the long-Term rIsk, clinical manaGement, and healthcare Resource utilization of stable coronary artery dISease in post-myocardial infarction patients (TIGRIS) study.

Authors:  Dirk Westermann; Shaun G Goodman; José C Nicolau; Gema Requena; Andrew Maguire; Ji Yan Chen; Christopher B Granger; Richard Grieve; Stuart J Pocock; Stefan Blankenberg; Ana Maria Vega; Satoshi Yasuda; Tabassome Simon; David Brieger
Journal:  Clin Cardiol       Date:  2017-12-16       Impact factor: 2.882

Review 7.  Long-term outcomes in high-risk patients with non-ST-segment elevation myocardial infarction.

Authors:  Marc Cohen
Journal:  J Thromb Thrombolysis       Date:  2016-04       Impact factor: 2.300
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.